Opus Genetics reports conference presentations
- Presented data on OPGx-BEST1 and OPGx-LCA5 trials
- Presentations held at Retina in Rio 2026 on Oct 14, 2026
- Press release and presentations filed as exhibits
IRD
Opus Genetics, Inc. SEC filings
Every EDGAR filing for Opus Genetics, Inc. (IRD), newest first, with AI summaries and stories.
- Ticker
- IRD
- CIK
- 1228627
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 open-market sale ($2.8M).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE4Opus Genetics, Inc.IRDLIVE Opus Genetics, Inc. shares sold by IRD
- Sold 556,000 shares on 09/30/2026
- Price range $4.95 to $5.29
- Owned 3,236,171 shares after transaction
Foundation Fighting Blindness Retinal Degeneration Fund · Foundation Fighting Blindness, Inc.
ROUTINE4Opus Genetics, Inc.IRDLIVE George Magrath, insider filing for IRD
George Magrath, reporting
ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE4Opus Genetics, Inc.IRDLIVE 2 insider filings
Robert E. Gagnon, insider filing for IRD
Show all 2
- 4Insider filing for IRD
- 4Insider filing for IRD
Robert E. Gagnon, reporting
ROUTINE144Opus Genetics, Inc.IRDLIVE Robert E. Gagnon, planned sale of IRD shares
Robert E. Gagnon, reporting
ROUTINEEFFECTOpus Genetics, Inc.IRDLIVE ROUTINESCHEDULE 13G/AOpus Genetics, Inc.IRDLIVE 2 13G filings
Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
PERCEPTIVE ADVISORS LLC, filed by
ROUTINESCHEDULE 13G/AOpus Genetics, Inc.IRDLIVE Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)
BALYASNY ASSET MANAGEMENT L.P., filed by
NOTABLE10-QOpus Genetics, Inc.IRDLIVE ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE4Opus Genetics, Inc.IRDLIVE 4 insider filings
Benjamin R Yerxa, insider filing for IRD
Show all 4
- 4Insider filing for IRD
- 4Insider filing for IRD
- 4Insider filing for IRD
- 4Insider filing for IRD
Benjamin R Yerxa, reporting
ROUTINE144Opus Genetics, Inc.IRDLIVE 2 Form 144 notices
Robert E. Gagnon, planned sale of IRD shares
Show all 2
- 144Planned insider sale of IRD shares
- 144Planned insider sale of IRD shares
Robert E. Gagnon, reporting
ROUTINE144Opus Genetics, Inc.IRDLIVE 2 Form 144 notices
Joseph K Schachle, planned sale of IRD shares
Show all 2
- 144Planned insider sale of IRD shares
- 144Planned insider sale of IRD shares
Joseph K Schachle, reporting
ROUTINE424B2Opus Genetics, Inc.IRDLIVE ROUTINEEFFECTOpus Genetics, Inc.IRDLIVE ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINES-3Opus Genetics, Inc.IRDLIVE NOTABLESCHEDULE 13D/AOpus Genetics, Inc.IRDLIVE Ownership stake disclosure by Foundation Fighting Blindness Retinal Degeneration Fund (amended)
Foundation Fighting Blindness Retinal Degeneration Fund, filed by
ROUTINE4Opus Genetics, Inc.IRDLIVE Foundation Fighting Blindness Retinal Degeneration Fund, insider filing for IRD
Foundation Fighting Blindness Retinal Degeneration Fund, reporting · Foundation Fighting Blindness, Inc., reporting
ROUTINESCHEDULE 13G/AOpus Genetics, Inc.IRDLIVE 2 13G filings
Ownership stake disclosure by Nantahala Capital Management, LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Nantahala Capital Management, LLC, filed by
ROUTINESCHEDULE 13GOpus Genetics, Inc.IRDLIVE Ownership stake disclosure by Caligan Partners LP
Caligan Partners LP, filed by
ROUTINESCHEDULE 13G/AOpus Genetics, Inc.IRDLIVE Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)
BALYASNY ASSET MANAGEMENT L.P., filed by
ROUTINES-8Opus Genetics, Inc.IRDLIVE ROUTINESCHEDULE 13G/AOpus Genetics, Inc.IRDLIVE Ownership stake disclosure by BIOS Fund III, LP (amended)
BIOS Fund III, LP, filed by
ROUTINESCHEDULE 13GOpus Genetics, Inc.IRDLIVE Ownership stake disclosure by Adage Capital Management, L.P.
Adage Capital Management, L.P., filed by
NOTABLE10-QOpus Genetics, Inc.IRDLIVE ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE4Opus Genetics, Inc.IRDLIVE 6 insider filings
Benjamin R Yerxa, insider filing for IRD
Show all 6
- 4Insider filing for IRD
- 4Insider filing for IRD
- 4Insider filing for IRD
- 4Insider filing for IRD
- 4Insider filing for IRD
- 4Insider filing for IRD
Benjamin R Yerxa, reporting
ROUTINE8-KOpus Genetics, Inc.IRDLIVE ROUTINE144Opus Genetics, Inc.IRDLIVE 2 Form 144 notices
Joseph K Schachle, planned sale of IRD shares
Show all 2
- 144Planned insider sale of IRD shares
- 144Planned insider sale of IRD shares
Joseph K Schachle, reporting
ROUTINE144Opus Genetics, Inc.IRDLIVE 3 Form 144 notices
George Magrath, planned sale of IRD shares
Show all 3
- 144Planned insider sale of IRD shares
- 144Planned insider sale of IRD shares
- 144Planned insider sale of IRD shares
George Magrath, reporting